Caricamento...
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
This phase I was study conducted to establish the maximum tolerated dose, dose-limiting toxicity, and recommended dose of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer. Twenty-six patients were treated with cyclophosphamide (600 mg m(−2), intr...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2002
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376193/ https://ncbi.nlm.nih.gov/pubmed/12402144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600626 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|